Journals / The Anatolian Journal of Cardiology / 2016 / Cilt: 16 - Sayı: 8

Association between carotid intima-media thicknessand presence of coronary artery disease in chronicobstructive pulmonary disease patients

Pages
601–607
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further studies are needed to validate our results.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Chronic obstructive pulmonary disease (COPD) is a risk factor for cardiovascular disease (CVD).
📊
Key Findings & Data:Therefore, the aim of this study was to evaluate whether CIMT measurement is related with significant coronary artery disease (CAD) in patients with COPD, similar to those without COPD.Methods: One hundred and eight patients with previously diagnosed COPD and 78 patients without COPD who underwent coronary angiography (CAG) were enrolled in this prospective cross-sectional study.
💡
Conclusion & Impact:Further studies are needed to validate our results.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Chronic obstructive pulmonary disease (COPD) is a risk factor for cardiovascular disease (CVD). Carotid intima-media thickness (CIMT) is the sign of subclinical atherosclerosis. Therefore, the aim of this study was to evaluate whether CIMT measurement is related with significant coronary artery disease (CAD) in patients with COPD, similar to those without COPD.Methods: One hundred and eight patients with previously diagnosed COPD and 78 patients without COPD who underwent coronary angiography (CAG) were enrolled in this prospective cross-sectional study. Carotid artery ultrasonography was performed on all patients after coronary angiography by another operator who was blind to the CAG results. The patients were divided into four subgroups as follows: group 1: COPD (&#8722;) and CAD (&#8722;); group 2: COPD (&#8722;) and CAD (+); group 3: COPD (+) and CAD (+); and group 4: COPD (+) and CAD (&#8722;). Patients with previous coronary revascularization, carotid artery disease, and lung disease other than COPD were not enrolled in this study. The student s t-test, chi-square analysis, multiple logistic regression analysis, and receiver operating characteristic (ROC) curve were used for statistical analysis.Results: CIMT was found to be highest in patients with both significant CAD and COPD (group 3) (p<0.05). Among the 108 COPD patients, the odds ratio associated with the CIMT >1.25 mm to predict CAD was 12.4. The area under the ROC curve for a cut-off value of 1.25 mm for CIMT to predict CAD in COPD patients was calculated as 0.913, with a sensitivity of 89.7% and specificity of 86.7%.Conclusion: CIMT has a predictive value for the presence of CAD in patients with COPD. Further studies are needed to validate our results.

🔖

Cite This Article

KÖSEOĞLU, C., KURMUŞ, Ö., ERTEM, A. G., ÇOLAK, B., BİLEN, E., İPEK, G., DURMAZ, T., KELEŞ, T., BOZKURT, E. (2016). Association between carotid intima-media thicknessand presence of coronary artery disease in chronicobstructive pulmonary disease patients. The Anatolian Journal of Cardiology, Cilt: 16 - Sayı: 8, 601–607. https://ajindex.com/articles/365464

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Global strategy of diagnosis, management and preventing chronic obstructive disease; 2011. www.goldcopd.org. Date last updated: January 2014
  2. Murray CJ, Lopez AD. Global mortality, disability and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997; 349: 1436-42
  3. Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States,1970-2002. JAMA 2005;294:1255-9
  4. Sin DD, Man SF. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc 2005; 2: 8-11
  5. Maclay JD, MacNee W. Cardiovascular disease in COPD: mecha-nisms. Chest 2013; 143: 798-807
  6. Mullerova H, Agusti A, Erqou S, Mapel DW. Cardiovascular comor-bidity in COPD: Systematic literature review. Chest 2013; 144: 1163-78
  7. Sidney S, Sorel M, Quesenberry CP Jr, DeLuise C, Lanes S, Eisner MD. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest 2005; 128: 2068-75
  8. Anthonisen NR, Connett JE, Enright PL, Manfreda J. Lung Health Study Research Group. Hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med 2002; 166: 333-9
  9. Nambi V, Chambless L, He M, Folsom AR, Mosley T, Boerwinkle E, et al. Common carotid artery intima-media thickness is a good as carotid intima-media thickness of all carotid artery segments in improving prediction of coronary heart disease risk in the Athero-sclerosis Risk in Communities (ARIC) study. Eur Heart J 2012; 33: 183-90
  10. Lorenz MW, Schaefer C, Steinmetz H, Sitzer M. Is carotid intima media thickness useful for individual prediction of cardiovascular risk? Ten-year results from the Carotid Atherosclerosis Progres-sion Study (CAPS). Eur Heart J 2010; 31: 2041-8
  11. Cao JJ, Arnold AM, Manolio TA, Polak JF, Psaty BM, Hirsch CH, et al. Association of carotid artery intima-media thickness, plaques, and C-reactive Protein with future cardiovascular disease and all-cause mortality: The Cardiovascular Health Study. Circulation 2007; 116: 32-8
  12. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: A systematic review and meta-analysis. Circulation 2007; 115: 459-67
  13. Androulakis AE, Andrikopoulos GK, Richter DJ, Tentolouris CA, Avgeropoulou CC, Adamopoulos DA, et al. The role of carotid ath-erosclerosis in the distinction between ischaemic and non-isch-aemic cardiomyopathy. Eur H